merck &amp co sleep aid drug test is ended due to lackluster results merck &amp co said it ended testing of its insomnia drug candidate gaboxadol because of disappointing late stage trial results merck based in whitehouse station n j has been developing the sleep aid since with danish drug maker h lundbeck as phase iii clinical study data suggested that gaboxadol didnt support further development the companies said lundbeck will lay off the staff it had built up in the u s for the prepared rollout of the drug in copenhagen lundbeck shares fell to danish kroner &# 
